The Mouth’s Microbes May Hold Clues to Cancer’s Origins

The human mouth is home to the second-largest microbial community in the body, a teeming ecosystem of bacteria, fungi, and viruses that begins colonizing within minutes of birth. For decades, dentists and microbiologists have studied this community for its role in cavities and gum disease, but a sweeping new review published in Holistic Integrative Oncology argues that the oral microbiome may be far more consequential than previously imagined. Compiled by Xiaoxuan Liu, Shan Liu, and Zhi Guo of Affiliated Nanshan Hospital of Shenzhen University, the review synthesizes a rapidly growing body of evidence linking oral microbial imbalance, or dysbiosis, to cancers far beyond the mouth, including colorectal, gastric, pancreatic, lung, and liver malignancies. The picture that emerges is one of a microbial gateway whose disturbance may ripple through the entire body, shaping inflammation, immunity, and metabolism in ways that can nurture tumors.

The scale of the oral ecosystem alone is striking. Based on 16S rDNA profiling, the dominant bacterial phyla in a healthy mouth, Firmicutes, Actinobacteria, Proteobacteria, Fusobacteria, Bacteroidetes, and Spirochaetes, together account for roughly 96 percent of oral bacteria. These microbes occupy distinct ecological niches, from supragingival and subgingival plaque to the tongue, buccal mucosa, saliva, and tonsils, each hosting its own characteristic community assembly. Notably, the oral microbiome shows significant variation between individuals but remarkable stability within a single person over time, exhibiting less temporal fluctuation than communities at sites like the gut or skin. That stability, the authors suggest, makes the mouth an ideal biological system for microbiome research, and potentially a reliable window into systemic health. Salivary gland function, oral clearance rates, pH, and secretory immunoglobulin A levels all act as regulators of this balance, and when any of them falter, the stage is set for dysbiosis.

Under healthy conditions, the oral community functions as a defensive barrier, resisting colonization by exogenous pathogens through competition and the inhibitory effects of microbial metabolites. But the review emphasizes that the boundary between commensal and pathogen is porous. Opportunistic species such as Porphyromonas gingivalis and Fusobacterium nucleatum, ordinarily tolerated members of the oral flora, can turn inflammatory and carcinogenic when the delicate equilibrium of the community is disrupted. In a dysbiotic state, these organisms and their metabolic products activate extracellular matrix degradation pathways and interfere with immune-related signaling, contributing to a chronic pro-inflammatory state that favors tumorigenesis. The review also connects this imbalance to acute systemic conditions, noting that oral dysbiosis has been associated with acute respiratory distress syndrome and sepsis through oral-intestinal axis-mediated changes in gut flora, underscoring that the mouth’s influence extends well beyond oncology.

Central to the review’s argument is the concept of oral-systemic axes, the routes by which oral microbes establish communication with microbial communities in distant organ systems. More than half of microbial genera can be detected in both the oral cavity and the gut, and oral organisms can migrate directly to the intestinal mucosa via the digestive tract or disseminate through the bloodstream. One vivid example involves periodontitis: pathologically activated Th17 cells acquire gut tropism, migrate to inflamed intestines, are specifically reactivated by colonized oral pathogens, and subsequently induce colitis. In the tumor context, dysbiosis, colonization, and translocation of oral bacteria upregulate cytokines and inflammatory mediators that reshape the tumor microenvironment. Metabolites play a critical role as well. Lactate can recruit immunosuppressive cell types including regulatory T cells, tumor-associated macrophages, and myeloid-derived suppressor cells, while dietary tryptophan metabolites activate the aryl hydrocarbon receptor in myeloid cells, fostering an immunosuppressive milieu that supports pancreatic ductal adenocarcinoma growth.

The mechanistic detail is deepest for colorectal cancer, where Fusobacterium nucleatum has become something of a molecular celebrity. The bacterium’s outer membrane protein Fap2 binds to the Gal-GalNAc carbohydrate abundant on colorectal tumor cells, mediating bacterial enrichment within tumors, while its adhesin A binds E-cadherin on intestinal epithelial cells and activates beta-catenin signaling, driving uncontrolled cell proliferation. F. nucleatum also induces secretion of IL-8 and CXCL1 to promote cancer cell migration, recruits tumor-infiltrating immune cells via CEACAM1 to evade immune surveillance, and targets the long non-coding RNA ENO1-IT1 to enhance glycolysis and tumor growth. Strikingly, Fusobacterium strains isolated from colorectal tumors closely resemble strains from the same patients’ saliva, supporting the hypothesis that colonic dysbiosis is at least partly seeded from the mouth. Germ-free mice transplanted with human saliva have allowed researchers to track how oral bacteria colonize the gastrointestinal tract through continuous swallowing, hematogenous spread during periodontal bacteremia, and environmental changes in the gut that permit stable colonization.

Similar patterns appear across other malignancies. In gastric cancer, oral taxa such as Rothia, Eikenella corrodens, Bergeyella, and Capnocytophaga are enriched in the gastric mucosa of patients, and Helicobacter pylori is detected in the oral cavity as well as the stomach. Actinomyces, an emerging opportunistic pathogen, promotes autophagy and upregulates TLR4 expression in gastric carcinogenesis, while acid-producing bacteria drive excessive short-chain fatty acid and lactate production that fuels tumor angiogenesis. In pancreatic cancer, epidemiological studies consistently link poor oral hygiene and periodontal disease to elevated risk, and intracellular P. gingivalis has been shown to promote oncogenic behavior in pancreatic cancer cells by activating Akt signaling. Perhaps most provocatively, pancreatic cyst fluid from tumor patients harbors a microbial community overlapping substantially with the oral microbiota, and the hypoxic, immunosuppressive pancreatic tumor environment appears to offer favorable conditions for oral anaerobes. In lung cancer, reduced oral alpha-diversity is negatively associated with risk, and P. gingivalis colonization, encouraged by long-term smoking and alcohol consumption, promotes malignant progression.

The relationship runs in both directions, and cancer treatment itself reshapes the oral ecosystem. Chemotherapy commonly induces oral mucositis and xerostomia, disrupting the homeostasis between host defenses and commensal bacteria and opening portals for opportunistic infection; studies report increases in Streptococcus viridans group species and, after two weeks of treatment, in anaerobes such as F. nucleatum and Prevotella intermedia. Radiotherapy for head and neck cancers raises the abundance of Gram-negative bacteria and Candida, increases Lactobacillus across multiple oral sites, and reduces bacterial alpha-diversity, with the most frequent complication being mucositis whose severity tracks with microbial shifts. Encouragingly, early clinical evidence suggests probiotics may mitigate this damage, with Bacteroides and Bifidobacterium genera shown to boost immune cell number and activity, potentially enhancing anti-CTLA-4 and anti-PD-L1 immunotherapy while reducing treatment toxicity.

Prognostic and diagnostic implications are already taking shape. The Fusobacterium genus has been independently linked to poorer outcomes in pancreatic, oral squamous cell, and colorectal cancers, while salivary Candida carriage correlates with unfavorable prognosis in oral cancer and Malassezia enrichment with favorable prognosis. Higher oral microbial diversity within pancreatic tumors and richer, more even oral communities in non-small cell lung cancer patients have both been associated with longer survival, and diversity indices may serve as independent predictors of overall and relapse-free survival. On the diagnostic front, the numbers are eye-catching: salivary microbiome analysis achieved diagnostic accuracy exceeding 90 percent in a cohort of 47 oral squamous cell carcinoma patients, salivary screening for gastric cancer yielded area-under-curve values of 91 and 97 percent in separate studies, and combining oral with fecal microbiome profiles improved colorectal cancer detection to 95 percent specificity and 88 percent sensitivity, outperforming the standard fecal immunochemical test.

The authors are careful to temper enthusiasm with candor. Current research remains largely observational, limited by heterogeneous study designs, insufficient causal evidence in human cohorts, and persistent challenges in standardizing oral microbiome sampling and analysis, and the prognostic literature remains inconclusive given variations in population, geography, and sample size. Yet the translational trajectory is clear. Future work, they argue, should move beyond descriptive associations toward identifying specific microbial signatures and functional pathways, prioritizing standardized sampling, longitudinal designs, and multi-omics integration with clinical outcomes. Targeted antimicrobials, probiotics, and microbiota-regulating interventions could eventually reshape the oral ecosystem in ways unfavorable to tumor development or supportive of anti-tumor immunity. As a non-invasive, easily collected, and low-cost specimen, saliva may soon join blood and tissue as a routine medium for cancer screening, prognostic evaluation, and personalized medicine, transforming the humble dental checkup into a window on one of medicine’s most formidable diseases.

Subject of Research: The role of oral microbiota dysbiosis in tumorigenesis, cancer prognosis, and early detection

Article Title: Research advances in the correlation between oral microbiota and tumors

Article References: Liu, X., Liu, S., & Guo, Z. (2026). Research advances in the correlation between oral microbiota and tumors. Holistic Integrative Oncology, 5(1), Article 48. https://doi.org/10.1007/s44178-026-00270-z

Image Credits: AI Generated

DOI: 10.1007/s44178-026-00270-z

Keywords: oral microbiota, tumorigenesis, Fusobacterium nucleatum, Porphyromonas gingivalis, oral-gut axis, colorectal cancer, pancreatic cancer, dysbiosis, salivary biomarkers, chronic inflammation, microbiome, cancer screening